Literature DB >> 16920812

AMPK and metabolic adaptation by the heart to pressure overload.

Michael F Allard1, Hannah L Parsons, Ramesh Saeedi, Richard B Wambolt, Roger Brownsey.   

Abstract

Accelerated glycolysis in hypertrophied hearts may be a compensatory response to reduced energy production from long-chain fatty acid oxidation with 5'-AMP-activated protein kinase (AMPK) functioning as a cellular signal. Therefore, we tested the hypothesis that enhanced fatty acid oxidation improves energy status and normalizes AMPK activity and glycolysis in hypertrophied hearts. Glycolysis, fatty acid oxidation, AMPK activity, and energy status were measured in isolated working hypertrophied and control hearts from aortic-constricted and sham-operated male Sprague-Dawley rats. Hearts from halothane (3-4%)-anesthetized rats were perfused with KH solution containing either palmitate, a long-chain fatty acid, or palmitate plus octanoate, a medium-chain fatty acid whose oxidation is not impaired in hypertrophied hearts. Compared with control, fatty acid oxidation was lower in hypertrophied hearts perfused with palmitate, whereas it increased to similar values in both groups with octanoate plus palmitate. Glycolysis was accelerated in palmitate-perfused hypertrophied hearts and was normalized in hypertrophied hearts by the addition of octanoate. AMPK activity was increased three- to sixfold with palmitate alone and was reduced to control values by octanoate plus palmitate. Myocardial energy status improved with the addition of octanoate but did not differ between groups. Our findings, particularly the correspondence between glycolysis and AMPK activity, provide support for the view that activation of AMPK is responsible, in part, for the acceleration of glycolysis in cardiac hypertrophy. Additionally, they indicate myocardial AMPK is activated by energy state-independent mechanisms in response to pressure overload, demonstrating AMPK is more than a sensor of the heart's energy status.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920812     DOI: 10.1152/ajpheart.00424.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  19 in total

Review 1.  Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies.

Authors:  Stephen L Archer; E Kenneth Weir; Martin R Wilkins
Journal:  Circulation       Date:  2010-05-11       Impact factor: 29.690

Review 2.  Energy metabolism in heart failure and remodelling.

Authors:  Joanne S Ingwall
Journal:  Cardiovasc Res       Date:  2008-11-05       Impact factor: 10.787

Review 3.  AMP-activated protein kinase regulation and biological actions in the heart.

Authors:  Vlad G Zaha; Lawrence H Young
Journal:  Circ Res       Date:  2012-08-31       Impact factor: 17.367

4.  Metabolic efficiency promotes protection from pressure overload in hearts expressing slow skeletal troponin I.

Authors:  Andrew N Carley; Domenico M Taglieri; Jian Bi; R John Solaro; E Douglas Lewandowski
Journal:  Circ Heart Fail       Date:  2014-11-25       Impact factor: 8.790

Review 5.  Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy.

Authors:  E Dale Abel; Torsten Doenst
Journal:  Cardiovasc Res       Date:  2011-01-21       Impact factor: 10.787

6.  Ivabradine reduces heart rate while preserving metabolic fluxes and energy status of healthy normoxic working hearts.

Authors:  Benjamin Lauzier; Fanny Vaillant; Roselle Gélinas; Bertrand Bouchard; Roger Brownsey; Eric Thorin; Jean-Claude Tardif; Christine Des Rosiers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-21       Impact factor: 4.733

Review 7.  Glucose metabolism and cardiac hypertrophy.

Authors:  Stephen C Kolwicz; Rong Tian
Journal:  Cardiovasc Res       Date:  2011-05-01       Impact factor: 10.787

Review 8.  AMPK in cardiovascular health and disease.

Authors:  Najeeb A Shirwany; Ming-Hui Zou
Journal:  Acta Pharmacol Sin       Date:  2010-08-16       Impact factor: 6.150

9.  Cardiac Ryanodine Receptor (Ryr2)-mediated Calcium Signals Specifically Promote Glucose Oxidation via Pyruvate Dehydrogenase.

Authors:  Michael J Bround; Rich Wambolt; Haoning Cen; Parisa Asghari; Razvan F Albu; Jun Han; Donald McAfee; Marc Pourrier; Nichollas E Scott; Lubos Bohunek; Jerzy E Kulpa; S R Wayne Chen; David Fedida; Roger W Brownsey; Christoph H Borchers; Leonard J Foster; Thibault Mayor; Edwin D W Moore; Michael F Allard; James D Johnson
Journal:  J Biol Chem       Date:  2016-09-12       Impact factor: 5.157

10.  Reactivation of fatty acid oxidation by medium chain fatty acid prevents myocyte hypertrophy in H9c2 cell line.

Authors:  Saifudeen Ismael; R Renuka Nair
Journal:  Mol Cell Biochem       Date:  2020-09-30       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.